SI-BONE Q1 revenue $52.6M (+11%), net loss improves 33.8%; raises FY26 guidance

SI-BONE, Inc.

• Worldwide revenue $52.6M (+11.2% YoY); US revenue $49.3M (+10.0%), international $3.3M (+33.9%).
• Net loss $4.3M (-33.8% YoY, -$0.10 diluted EPS); adjusted EBITDA $2.5M (vs $0.5M, >440% improvement).
• Gross margin stable at 79.8%; operating loss improved 31.9% to $5.1M.
• Raised FY2026 revenue guidance to $230-233M (prior $228.5-232.5M); gross margin ~79% (prior ~78%).
• Operational: over 1,650 active US physicians (+17%); CMS proposes new MS-DRG for complex spinal fusion with iFuse Bedrock Granite.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.